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Intensive research is devoted to unravel the neurobiological mechanisms mediating adult
hippocampal neurogenesis, its regulation by antidepressants, and its behavioral conse-
quences. Macrophage migration inhibitory factor (MIF) is a pro-inflammatory cytokine that is
expressed in the CNS, where its function is unknown. Here, we show, for the first time, the
relevance of MIF expression for adult hippocampal neurogenesis. We identify MIF expression
in neurogenic cells (in stem cells, cells undergoing proliferation, and in newly proliferated cells
undergoing maturation) in the subgranular zone of the rodent dentate gyrus. A causal function
for MIF in cell proliferation was shown using genetic (MIF gene deletion) and pharmacological
(treatment with the MIF antagonist Iso-1) approaches. Behaviorally, genetic deletion of
MIF resulted in increased anxiety- and depression-like behaviors, as well as of impaired
hippocampus-dependent memory. Together, our studies provide evidence supporting a
pivotal function for MIF in both basal and antidepressant-stimulated adult hippocampal cell
proliferation. Moreover, loss of MIF results in a behavioral phenotype that, to a large extent,
corresponds with alterations predicted to arise from reduced hippocampal neurogenesis.
These findings underscore MIF as a potentially relevant molecular target for the development
of treatments linked to deficits in neurogenesis, as well as to problems related to anxiety,
depression, and cognition.
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Introduction
Macrophage migration inhibitory factor (MIF) was
originally identified as a T-lymphocytes-derived pro-
inflammatory cytokine that inhibits the random
migration of macrophages.1,2 In the immune system,
MIF is released in response to inflammatory stimuli
including microbial products and glucocorticoid
hormones.3–5 In addition to this pro-inflammatory
function, MIF is produced by many other non-
immune cells within the body, with high expression
levels found in the liver, kidney, anterior pituitary,
and brain.6,7
Although the function of MIF in the mature
mammalian brain remains unclear, evidence from
other organs has identified a function in cellular
proliferation. For example, in macrophage cells, MIF
acts as an inhibitor of p53 tumor suppressor activ-
ity.8,9 In fibroblasts, MIF was shown to induce cyclin
D1 expression and cell cycle progression through
activation of the ERK/MAPK cascade.10 Interestingly,
indirect evidence suggests that MIF may also be
involved in cellular proliferation in the CNS.10,11 In
the bovine adult brain, MIF expression has been
reported in granular cells of the dentate gyrus.12 In
situ hybridization has localized MIF in ependymal
cells lining the ventricular surfaces and epithelial
cells of the choroid plexus, as well as in neurons and
astrocytes distributed all over the adult rat brain.13
Interestingly, both the hippocampus and the ventri-
cles are areas of ongoing cellular proliferation
(eventually leading to neurogenesis) in the adult
brain.
The subgranular zone (SGZ) of the hippocampal
dentate gyrus undergoes limited proliferation and
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differentiation of neuronal precursors (neurogenesis)
in adulthood.14 Progenitor cells in the SGZ can give
rise to new neurons, which, depending on a number
of environmental influences, can migrate into the
granule cell layer in which they differentiate into
granular neurons15 and may subsequently become
functionally integrated into the hippocampal circui-
try.16–18 Therefore, we aimed here to ascertain the
relevance of MIF expression for adult hippocampal
neurogenic processes. First, we identified MIF ex-
pression in neurogenic niches of the rodent dentate
gyrus and characterized the cellular phenotype. To
establish a link between MIF and neurogenesis, we
used models of altered [both negatively (chronic
stress and corticosterone administration) and posi-
tively (antidepressant treatment)] adult neurogenesis,
whereas the causal function of MIF in basal and
antidepressant-stimulated neurogenesis was ad-
dressed through pharmacological and knockout ge-
netic approaches. Finally, the behavioral implications
of MIF deficiency were also explored.
Materials and methods
Animals
Adult male Wistar rats (3 months), purchased from
Charles River (France), were used for the chronic
stress experiment. MIF knockout (MIF/) mice were
produced as described earlier19 and kept under
C57BL/6N background [wild-type (WT) controls from
this background were obtained from Charles River at 8
weeks of age]. MIF/ mice were bred and weaned at
the Centre Hospitalier Universitaire Vaudois Lau-
sanne and, at approximately 6–8 weeks of age,
transported to EPFL for testing. Animals were housed
in groups of 3–4 under temperature- and humidity-
controlled conditions, and were maintained on a 12h
light/dark cycle with free access to food and water. On
delivery to EPFL, animals were allowed to rest for 2
weeks before commencement of testing. Animal
experiments were approved through a license issued
by the Cantonal Veterinary Authorities (Vaud, Swit-
zerland).
50Bromodeoxyuridine administration
We have followed two different protocols for
50bromodeoxyuridine (BrdU; a thymidine analog)
administration. For the studies of colocalization
between MIF and dividing cells, we injected BrdU
(100mgkg–1, intraperitoneally (i.p.); Sigma-Aldrich,
St Louis, MO, USA) dissolved in phosphate buffer
(0.1M) 2h before killing. For experiments addressed
to investigate the survival of the newly proliferated
cells, four injections of BrdU (50mgkg–1, i.p.) were
given, one every 12h, over a period of 2 days, and 15
days before killing.
Tissue preparation for immunohistochemistry
Rats and mice were perfused transcardially under
deep chloral hydrate anesthesia, with saline and then
4% paraformaldehyde in sodium phosphate buffer
0.1M, pH 7.4. After perfusion, the brains were
extracted and cryoprotected with 30% sucrose in
phosphate buffer. Coronal sections (50 mm) were
obtained with a sliding microtome and stored at
20 1C in 30% glycerol; 30% ethylene glycol, 40% PB
until used.
Immunohistochemistry for conventional light
microscopy
For immunohistochemistry, the tissues were pro-
cessed using free-floating conditions as follows.
Briefly, sections were incubated with 10% methanol,
3% H2O2 in phosphate-buffered saline (PBS) for
10min to block endogenous peroxidase activity. After
this, sections were treated for 1h with 5% normal
donkey serum (Jackson ImmunoResearch Labora-
tories, West Grove, PA, USA) in PBS with 0.2%
Triton-X 100 (Sigma-Aldrich) and were incubated
overnight at room temperature in polyclonal rabbit
anti-MIF antibody (1:1000; Zymed, Paris, France),
monoclonal mouse anti-ki67 antibody (1:200; Novo-
castra, Newcastle upon Tyne, UK), monoclonal mouse
anti-proliferating cell nuclear antigen antibody
(PCNA, 1:200; Sigma-Aldrich), polyclonal goat anti-
doublecortin (DCX) antibody (1:200, Santa Cruz, CA,
USA), or monoclonal mouse anti-vimentin antibody
(1:500, DSHB). After washing, sections were incu-
bated for 30min with donkey anti-mouse IgG, donkey
anti-rabbit IgG or donkey anti-goat IgG biotinilated
antibodies (1:250; Jackson ImmunoResearch Labora-
tories), followed by an avidin–biotin–peroxidase
complex (ABC; Vector Laboratories, Peterborough,
UK) for 30min in PBS. Color development was
achieved by incubating with 3,30 diaminobenzidine
tetrahydrochloride (Sigma-Aldrich) for 4min. PBS
containing 0.2% Triton-X 100 and 3% normal donkey
serum was used for primary and secondary antibodies
dilution. All of the sections studied passed through
all procedures simultaneously to minimize any
difference from immunohistochemical staining itself.
In the case of BrdU immunohistochemistry, en-
dogenous peroxidase activity was inhibited as above,
then sections were denatured by incubation for 1h at
60 1C. After cooling to room temperature, the sections
were incubated with 2N HCl for 30min and then
incubated overnight with monoclonal rat anti-BrdU
antibody (1:500; Oxford Biotechnology, Oxford, UK)
followed by donkey anti-rat IgG biotinilated antibody
(as described above).
Double immunohistochemistry for confocal microscopy
To characterize the phenotype of MIF-immunoreac-
tive (IR) elements in the dentate gyrus, we performed
double immunohistochemistry using anti-MIF and
antibodies against different neuronal, astroglial, mi-
croglial, and oligodendroglial markers. We analyzed
whether the MIF-IR elements are also IR for different
stages of cell proliferation and neurogenesis by using
Ki67 and BrdU to mark cell proliferation, vimentin,
and anti-glial fibrillar acidic protein (GFAP) for stem
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cells, and PSA-NCAM, DCX, and NeuroD for neuronal
precursors.
In general, sections were processed as described
above, but the endogenous peroxidase block was
omitted. The sections were incubated overnight with
rabbit polyclonal anti-MIF antibody (1:1000; Zymed)
and one of the following primary IgG antibodies:
monoclonal mouse anti-neuronal nuclear antigen
(1:100; NeuN, Chemicon, CA, USA), polyclonal rabbit
GFAP (1:500; Sigma-Aldrich), monoclonal mouse
anti-vimentin (1:500, DSHB), monoclonal mouse RIP
(1:500, DSHB), polyclonal goat anti-NeuroD (1:200,
Santa Cruz Biotechnology, Santa Cruz, CA, USA),
polyclonal goat anti-DCX (1:200; Santa Cruz Biotech-
nology), monoclonal mouse anti-ki67 (1:200; Novo-
castra), and mouse IgM anti-PSA-NCAM (Abcys,
Paris, France; 1:1400). After washing, sections were
incubated with donkey anti-mouse IgM, donkey anti-
mouse IgG, donkey anti-goat IgG, or donkey anti-
rabbit IgG secondary antibodies conjugated with
Alexa 488 or Alexa 555 (1:200; Molecular Probes,
OR, USA) in PBS containing 0.2% Triton-X 100 and
3% normal donkey serum. These general processing
of the sections was slightly modified in two cases.
The first one was when using the marker for
microglia, the biotinylated tomato lectin (1:50, Sigma-
Aldrich). After washing, sections were incubated
with biotin conjugated with Alexa 488 (1:200,
Molecular Probes) in the same solution than the
secondary antibodies. The second exception was for
the BrdU analyses. In this case, sections were firstly
denatured by incubation for 1h at 60 1C. After cooling
to room temperature, the sections were incubated
with 2N HCl for 30min and then incubated overnight
with the mix of polyclonal rabbit anti-MIF and
monoclonal rat anti-BrdU antibody (1:500; Oxford
Biotechnology) followed by donkey anti-rabbit IgG and
donkey anti-rat IgG conjugated with Alexa 488 or 555
(as described above).
Sections were mounted on slides and coverslipped
using DakoCytomation fluorescent medium (Dako
North America, Inc., Carpinteria, CA, USA). Then,
they were observed under a confocal microscope
(Leica TCS SPE) using a 63X oil objective. Z-series of
optical sections (1mm apart) were obtained using the
sequential scanning mode. These stacks were pro-
cessed with LSM 5 image software. One in 10 series of
hippocampal sections from each animal was double
labeled as described. Fifty randomly selected IR cells
were analyzed in each case to determine the co-
expression of MIF and the markers described above
(Table 1).
Immunohistochemical quantification
The number of Ki67-, PCNA-, BrdU-, DCX-, PSA-
NCAM-, vimentin-, and MIF-IR cells in the dentate
gyrus was estimated using a modified version of the
fractionator method.20 Systematic-random series
(1:10) of sections covering the entire rostral to caudal
extension of this structure were viewed on an
Olympus BX40 microscope. Within each section,
cells covering 100% of the sample area (that is all
dentate gyrus-labeled cells) were counted. Cell soma-
ta were identified and counted with a 40 objective
lens. Cells appearing in the upper focal plane were
omitted to prevent counting cell caps. The boundaries
of the dentate gyrus were determined in parallel
series of sections stained with cresyl violet. After
cresyl violet staining, the dentate gyrus size in WT
and MIF/ mice was measured by quantifying its
extension in every slice from a 1:10 subseries using
Image J software (NIH).
Chronic unpredictable stress
During the course of 3 weeks, 24 rats were exposed
daily to various stressors that were applied at
different times of the day and included bright light
(300 l , 30min), elevated platform (2h), predator
odor (1 h exposure to 10 ml of trimethylthiazoline, a
synthetic compound originally isolated from fox
feces), exposure to electric shocks (three 1 s shocks
of 0.4mA), exposure to the context reminder of
shocks, acoustic stimulation (78–115dB noise bursts),
forced swimming in tanks of different sizes, exposure
to a novel arena, and exposure to elevated plus maze
(EPM) (see below for details). Another 24 rats were
used as undisturbed controls. Animals were perfused
and their brains processed for immunohistochemistry
as described above.
Chronic treatment with corticosterone
Brain sections from an earlier published experiment
describing an effect of chronic corticosterone treat-
ment in hippocampal neurogenesis21 were used to
assess for the levels of MIF-IR cells in the dentate
gyrus. This method of corticosterone administration,
the plasma corticosterone levels, and variations in
organ weight induced by it have been described in
detail earlier.22 Animals were perfused and their
brains processed for immunohistochemistry as de-
scribed above.
Table 1 Percentage of MIF colocalization with each of the
markers used to identify different cell types and proliferation-
differentiation states in the SGZ of the hippocampus
Marker Mean±s.e.m.
MIF/BrdU 2h 4.0±0.5
MIF/Ki67 3.5±0.9
MIF/GFAP 96.0±1.2
MIF/Vimentin 94.5±1.3
MIF/Nestin 3.5±0.7
MIF/PSA-NCAM 6.5±0.9
MIF/Doublecortin 5.5±1.3
MIF/NeuroD 5.0±0.7
MIF/NeuN 0.0±0.0
MIF/Tomato lectin 0.0±0.0
MIF/RIP 0.0±0.0
Abbreviations: MIF, migration inhibitory factor; SGZ, sub-
granular zone.
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Drug treatments
Mice from each genotype (MIF/ and WT, n=8 per
genotype) were chronically administered with the
antidepressant fluoxetine [10mgkg–1, i.p., daily for 14
days; n=4 per group] or vehicle (0.9% NaCl; n=4 per
group). Treatment with Iso-1 (synthesized at the
Department of Chemistry, EPFL) [(S,R)-(4-hydroxy-
phenyl)-4,5-dihydro-5-isoxazole acetic acid methyl
ester] was also followed in WT animals. Iso-1 is a
potent inhibitor of MIF’s catalytic and cytokine
activity. Iso-1 (7mgkg–1, i.p. in 5% DMSO in 0.9%
NaCl) was injected daily for 14 days. Control mice
received vehicle (5% DMSO in 0.9% NaCl).
Corticosterone analyses
Plasma corticosterone levels were analyzed in two
cohorts of MIF/ and WT mice. On the first one
(MIF/ n=4, WT n=5), basal levels were collected
under resting conditions both in the morning and
evening by making a small cut close to the end of the
tail. On the second one (MIF/ n=8, WT n=8),
corticosterone response to stress was evaluated by
exposing mice to a novel environment (a confined
circular box of 25 cm diameter) during 15min. Blood
samples were taken immediately after stress (that is
15min from the start of stress, min-15) by a small tail
incision, and 15min after the end of the stress
procedure (that is 30min from the start of stress,
min-30) by decapitation. Plasma corticosterone was
quantified using Correlate-EIA Corticosterone En-
zyme Immunoassay Kit (Assay Design, MI, USA)
according to the manufacturer’s instructions.
Preparation of hippocampal tissue and western blot
analyses for corticosteroid receptors
Hippocampal tissue was collected under both basal
conditions (n=10 per genotype) and 30min after
exposure to stress (n=4 per genotype). Each mouse
hippocampus was homogenized in ice-cold homo-
genization buffer [10mM Hepes/1.0mM EDTA/2.0mM
EGTA/0.5mM DTT/0.1mM PMSF/1% NP-40] contain-
ing protease and phosphatase inhibitor cocktail
(Roche, Basel, Switzerland). Protein content in whole
hippocampal samples was quantified using the DC
protein assay (Bio-Rad Laboratories AG, Reinach,
Switzerland). Equal protein samples were prepared
at a concentration of 0.5mgml–1 in reducing SDS–
PAGE buffer (NEB). Proteins were resolved on 10%
polyacrylamide gels, and transferred to nitrocellulose
membranes. The membrane was then blocked in 5%
non-fat milk and rabbit anti-glucocorticoid (1:10 000;
Santa Cruz) and anti-mineralocorticoid (1:1000; Santa
Cruz) were applied in this blocker over night at 4 1C.
Peroxidase-labeled secondary anti-rabbit IgG was
applied for 1h at room temperature followed by
washing and band visualized using a chemilumines-
cence peroxidase substrate (SuperSignal West Dura,
Pierce Biotechnology, IL, USA). Immunoreactivity
was detected using the Biorad ChemiDoc XRS system.
Densitometry analysis on the bands was calculated
using Biorad Quantity One (4.2.3) software (Bio-Rad
Laboratories AG). Absorbance for each of the synaptic
protein antibodies was normalized to within-lane
actin absorbance. Average densitometric data are
reported for each experimental group as percentage
of WT values.
General procedures for behavioral testing in MIF/
mice
Three cohorts of MIF/ and WT mice were tested at
10–14 weeks of age on a variety of behavioral tests. In
two of the cohorts, testing was initiated with the EPM.
Then, one of the cohorts was tested in the activity
cage (1 day afterward), in the Y-maze test, and in the
forced swim test (FST) (1 week inter-test interval).
The second cohort was tested in the water maze, in
the acoustic fear-conditioning task and in the hot-
plate test (1 week inter-test interval). A third cohort of
mice was only behaviorally tested in the FST. The
behavioral tests are described below. In all the tests
(except for the fear conditioning and hot-plate tests), a
video camera was used to videotape mice behavior
that was automatically recorded and analyzed by the
video tracking software (Ethovision, Noldus, Nether-
lands).
Elevated plus maze
Anxiety-like behavior was assessed using the EPM
task, a standardized test for anxiety-like behavior in
rodents. This test has been described in detail
earlier.23 Mice (n=26–28 per genotype) were placed
on the central platform facing a closed arm and
allowed to explore the maze for 5min. The total
distance moved, time spent, and number of entries to
the open, center, and closed arms were analyzed.
Differences in the proportion of time spent in the
open arms and close arms are indicative of differences
in anxiety-like behavior.
Forced swim test
The mice were individually placed into a glass
cylinder (25 cm height, 10 cm diameter) containing
8 cm of water maintained at 25–26 1C. The test lasted
5min. The time mice spent immobile was measured
during the last 4min of the test period. The floating
time, defined as the absence of escape-oriented
behaviors, such as swimming or climbing, was
scored. Percentage time immobile was calculated.
Spatial learning in the water maze
Mice from each genotype (MIF/ and WT, n=10 per
genotype) were tested for their spatial memory. A
detailed description of the maze and standard train-
ing conditions has been published earlier.23 Briefly,
training was conducted over 3 days (four trials per
day with a inter-trial interval of 15min). The latency
to find the platform was measured as an index of the
learning and memory abilities of the animals, as no
differences in swim speed were found between the
two genotypes. One day later (day 4), spatial memory
was tested in a probe test and percent time spent in
the target and opposite quadrant was measured and
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the bias toward the target quadrant served as an
indication of spatial memory. After the probe test, a
cued version of the water maze task, in which the
platform was made visible by attaching a 10 cm flag to
the base of the platform, was used to evaluate the
motivation and motor abilities of the WT and MIF/
mice.
Acoustic fear conditioning
Details of the apparatus and training procedure have
been described in detail elsewhere.24 Fear condition-
ing to the tone was performed on male mice (n=8–9/
genotype). All trials were video recorded and freez-
ing, which is defined as behavioral immobility, except
for respiration movements for at least 2 s, was meas-
ured by an experimenter blind to the genotype of the
animals. Freezing times were transformed to percen-
tage freezing values.
Hot-plate test
Mice (n=10 per genotype) were tested for their
analgesic sensitivity using a hot-plate apparatus.
The temperature was set at 51±0.1 1C and the cut-
off time to stop the trial was 60 s. The parameters
recorded were the latencies to front-paw licking, to
hind-paw licking, and to jump (all four paws off
surface simultaneously).
Statistics
All data for quantitative studies are expressed as
mean±s.e.m. Data was analyzed with Student’s two-
tailed t-test (with Welch’s correction, where appro-
priate) or analysis of variance (one/two way or
repeated measures, depending on the experimental
design), followed by Bonferroni’s or Fischer’s LSD
post hoc analysis, where appropriate. Significance
was set at P<0.05.
Results
MIF expression in the SGZ of the hippocampus
We observed the presence of MIF-IR cells in several
areas of the rat brain including the neocortex (Figures
1e and f), amygdala, hippocampus (Figures 1a–c),
thalamic nuclei, and the rostral migratory stream
(Figure 1d). Attending to their morphology, MIF-IR
cells were small in size and had a multipolar shape
(resembling the size and shape of astrocytes) and co-
localized with GFAP (Supplementary Figure 2). Most
interesting to us, given the reported function of MIF
in cell division, was the high level of expression of
MIF in the SGZ of the dentate gyrus.
Therefore, we studied the expression of MIF in
proliferating cells in the dentate gyrus. In experi-
ments in which BrdU was injected 2h before killing
(to evidence proliferating cells), we observed the
expression of MIF (Figure 2a) and Ki67, a proliferative
marker (Figure 2b). Here, MIF-IR cells displayed
unipolar morphology (Figure 1c), but co-localized
with vimentin and GFAP (Figures 2c and d), markers
of astrocytes and present in stem cells, as well as with
nestin (Figure 2e) that is present in stem cells (type 1
in Kemperman’s classification), suggesting significant
MIF expression in cytogenic cells. We then undertook
a more detailed characterization of the phenotype of
these SGZ MIF-IR cells using double immunohisto-
chemistry against MIF and specific markers for cell
types at different states of proliferation/differentia-
tion. We did not observe colocalization between MIF
and NeuN, the latter a marker of mature neurons
(Figure 2g). In addition, we did not find evidence for
expression of MIF in neither microglia (using tomato
lectin) nor oligodendroglia (using RIP) (Supplemen-
tary Figure 1). Some MIF-IR cells co-localized with
PSA-NCAM, DCX, or NeuroD, markers for neuroblasts
and immature granule neurons in the SGZ of the
hippocampus (Figure 2f). The percentage of colocali-
zation between MIF and the different markers
analyzed is indicated in Table 1. Overall, these results
suggest a potentially functional role for MIF in
hippocampal neurogenesis, which we addressed in
the following sections.
Correlation between MIF expression and hippocampal
neurogenesis
The co-localization of MIF with known markers of
proliferative and newly differentiated neurons sug-
gested the possibility that MIF was important for
neurogenesis. To functionally link MIF expression in
the SGZ of the rat hippocampus to neurogenesis, we
studied two models involving impaired neurogenesis:
(i) chronic stress and (ii) chronic corticosterone
administration (CORT). First, we confirmed that
under our experimental conditions, chronic unpre-
dictable stress (CUS) induced a reduction in the
number of proliferative cells in the dentate gyrus, as
reflected by lower Ki67-IR expression in the stress
group than in the control (P<0.03; Figure 3a). In
parallel, we observed a clear reduction in the amount
of MIF-IR cells in the SGZ after CUS (P<0.002; Figure
3b). On the other hand, we observed no change in the
number of vimentin-IR cells in the SGZ of animals
under chronic stress (Figures 3c and d) (6096±342
cells in the control rats vs 5803±67 in stressed rats;
P=0.44). Vimentin is a marker for precursor cells that
we found to co-localize with MIF (Figure 2c); this
unaltered presence of vimentin in the MIF indicates
that precursor cells are present, but there is a deficit
in their proliferation. Second, we analyzed MIF
expression in brain slices from an earlier published
paper in which a chronic corticosterone treatment
was reported to reduce hippocampal neurogenesis21
Again, we found reduced MIF-IR cells in the
corticosterone-treated group as compared with the
control group (P<0.002) (Figure 3e).
MIF/ mice show lower levels of neurogenesis and
exhibit significantly reduced response to fluoxetine-
induced cell proliferation than WT mice
The fact that reduced neurogenesis was accompanied
by parallel reductions in MIF-IR expression in the
dentate gyrus suggested either that MIF was causally
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implicated in the proliferative deficit or that reduced
MIF expression was a consequence of the treatments’
effects on neurogenesis. To directly address this
causality issue, we compared expression levels in
the dentate gyrus of three markers (PCNA, DCX,
BrdU) for different neurogenic phases between WT
and MIF/ mice. We found a marked reduction in all
three markers of neurogenesis in MIF/ mice as
compared with controls: the difference was already
observed for cell proliferation (as indicated by PCNA-
IR; P<0.0001; Figure 4a), and was maintained for
differentiating/immature neurons (as indicated by
DCX-IR; P<0.0001; Figure 4b) and for cells surviving
for 3 weeks [time considered to be required for new
cells incorporation into the hippocampal circuitry25
as their proliferation (as indicated by BrdU-IR;
P<0.0003; Figure 4c)]. There was no significant
change in the level of precursor cells as evidenced
by unchanged levels of vimentin in the SGZ in MIF/
mice (5801±272 cells in the WT group vs 6358±411
in the MIF/ group; P=0.27). Moreover, the overall
size of the dentate gyrus was unaffected (data not
shown).
The former experiment established the causal im-
plication of MIF on cell proliferation under basal
conditions. We questioned, then, whether MIF would
also be required for cell proliferation. The SSRI
antidepressant fluoxetine has been found to stimulate
neurogenesis, particularly cell proliferation.26,27 There-
fore, we examined whether genetic deletion of MIF
would interfere with fluoxetine-induced cell prolifera-
tion. Fluoxetine (10mgkg–1, i.p.) was given daily
over 14 days. Analysis of variance with genotype
(WT and MIF/) and treatment (vehicle or fluoxetine)
as the between group factors revealed significant
effects of fluoxetine (F(1,12)=11.43; P=0.005), geno-
type (F(1,12)=68.76; P<0.0001), and an interaction
between the two factors (F(1,12)=9.37; P=0.01) on cell
proliferation (as indicated by PCNA-IR expression).
Post hoc tests indicated again lower cell proliferation in
Figure 1 MIF distribution in the brain. (a) Panoramic view of the hippocampus. (b) Detailed view of the dentate gyrus of the
hippocampus. (c) A more detailed view shows the presence of MIF-IR cells in the SGZ, a neurogenic area of the adult brain.
Asterisks mark cells MIF-IR in the SGZ with the unipolar characteristic morphology; fd, fascia dentata. Examples of
expression of MIF in other brain regions: rostral migratory stream (d), neo-cortex (e), and white matter (f). Scale bar: 1mm (a),
200 mm (b, d–f) and 50mm (c).
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MIF/ than inWTmice (vehicle injected in both cases;
P<0.01). Moreover, whereas fluoxetine treatment in-
creased cell proliferation in WTmice as compared with
vehicle-injected mice (P<0.01), it had no effect in
MIF/ mice (P<0.001; Figure 4d). The same differ-
ences were observed in immature neurons (as indicated
by DCX labeling; data not shown).
In this latter experiment, we also measured MIF-IR
in the dentate gyrus of WT mice after fluoxetine
treatment. Interestingly, a significant increase was
Figure 2 Phenotypical characterization of MIF-IR cells in the hippocampal SGZ. Colocalization of MIF and BrdU (a) and
MIF and Ki67 (b) reveals that MIF-IR cells have the ability to proliferate. Colocalization of MIF and vimentin (c) and MIF and
GFAP (d) reveals that these cells displayed astrocytic-stem cell nature. The observed colocalization between MIF and Nestin
(e) confirmed the stem-cell nature of these cells (type 1). Some MIF-IR cells displayed colocalization with NeuroD (f)
revealing the clear immature nature of those cells. (g) MIF-IR cells does not colocalize with the neuronal marker NeuN; fd,
localization of granule cell layer. Scale bar. 25mm. Images correspond to focal planes.
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found in fluoxetine-treated mice as compared with
saline-treated mice (P<0.05; Figure 4e), mimicking
the enhanced cell proliferation induced by this
treatment (Figure 4d).
Finally, pharmacological inhibition of MIF (with 14
days of iso-1 treatment), mimicking post-natal MIF
deletion, also modulated hippocampal neurogenesis.
Iso-1-treated mice showed a lower number of Ki67-IR
cells in the dentate gyrus than vehicle-injected mice
(P=0.04; Figure 4f). See Supplementary Figure 3 for
pilot data indicating that MIF antagonist Iso-1 can
also reduce fluoxetine-stimulated cell proliferation.
Plasma glucocorticoid levels and hippocampal
corticosteroid receptors in MIF/ mice
As MIF/ and WT mice differed in their neurogenic
responses, and given that there is a link between MIF
and glucocorticoids,7 and glucocorticoids are known
to regulate hippocampal neurogenesis,28 we set
experiments to evaluate plasma corticosterone levels
and hippocampal expression of the two types of
corticosteroid29 (mineralocorticoid, and glucocorti-
coid) receptors both under basal conditions and in
response to stress. As shown in Figure 5a, left panel,
no significant differences in plasma corticosterone
levels between the two genotypes were observed
when blood samples were taken under basal condi-
tions at different times during the circadian cycle
(F(1,7) = 0.80; P=0.40). Again, when a second cohort
of mice was briefly exposed to novelty stress (Figure
5a, right panel), no significant differences in corti-
costerone responses were observed when plasma
samples were taken 15 and 30min from the beginning
of the stress procedure (F(1,14) = 2.34; P=0.15).
Similarly, no differences between the two genotypes
were found for hippocampal mineralocorticoid or
glucocorticoid expression when evaluated under
basal conditions (Figure 5b, left panel; n.s.) or after
exposure to stress (Figure 5b, right panel; n.s.).
Characterization of anxiety- and depression-like
behaviors in MIF/ mice
At the behavioral level, hippocampal neurogenesis
has been linked to affective behaviors such as
anxiety,30 depression,31 and to cognitive functions
such as learning and memory.32,33 Therefore, we
characterized these behaviors in the MIF/ mice.
Analysis of behavior in the EPM indicated higher
indices of anxiety in MIF/ mice than in controls:
mutant mice displayed fewer entries (P<0.01; Figure
6a) and spent less time in (P<0.001; Figure 6b) the
open arms than WT mice. MIF/ also moved
significantly less in all areas of the EPM (Figure 6c).
This reduced exploration was further confirmed in
the activity cage, with MIF/mice moving significantly
Figure 3 Modulation of MIF in the SGZ by treatments affecting hippocampal cell proliferation (chronic stress, stress
hormones administration, and fluoxetine). CUS leads to a reduction in (a) the proliferative marker Ki67 and (b) a
corresponding reduction in expression of MIF-IR cells in the rat SGZ. (c and d) These changes are not related to changes in
hippocampal vimentin expression between (c) control and (d) CUS. (e) Chronic treatment with corticosterone induces a
similar reduction in MIF expression in the SGZ zone of the dentate gyrus. All data represents mean±s.e.m. *P<0.05 and
**P<0.01 compared with corresponding control. Scale bar 100mm.
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shorter distance than WT controls (P<0.01; data
not shown).
Depression-like behavior was evaluated in the FST.
MIF/ mice spent significantly more time immobile
than WT mice (P<0.05; Figure 6d), which is sugges-
tive of higher depression-like behavior in the mutant
mice. However, in a pilot study performed in
behaviorally naive mice, depression-like behavior
(that is floating) in the FST was equivalent for MIF/
and WT mice (Supplementary Figure 4).
Performance of MIF/ mice in hippocampus-
dependent and -independent learning tasks
Spatial learning and memory abilities of MIF/ and
WT mice were tested in the hippocampus-dependent
water maze task.34,35 A repeated measures analy-
sis of variance indicated (i) a significant effect of
time (F(11,198) = 6.60; P<0.001), with animals
showing reduced escape latencies over training trials
(Figure 7a); (ii) a significant overall effect of genotype
(F(1,18) = 6.34; P=0.02), with MIF/mice performing
worse than WT controls; and (iii) a significant inter-
action between time and genotype (F(11,198) = 2.45;
P=0.007). Post hoc analyses indicated that MIF/
mice performance was particularly impaired on the
first trial of day 3 (Trial 9; P<0.05), suggesting a
deficit for the mutant mice in the long-term memory.
Further evidence of the long-term memory dysfunc-
tion in these mice was found in the probe test,
conducted 24h after the last trial on day 3. Whereas
WT mice showed a clear preference for the target vs
the opposite quadrant (P<0.0001), MIF/ mice failed
to show this preference (n.s.) (Figure 7b), performing,
in fact, at random (that is their time in the target
quadrant did not differ from 25%, chance level). To
check whether the cognitive deficit observed in the
MIF/ mice was not related to a motor deficit or
altered motivation, we performed a further training
session in which the platform was made visible
(cued) to the mice. Here, no differences were found
between MIF/ and WT animals in their latencies to
find the platform (n.s.; Figure 7a, visible), suggesting
that the learning and memory deficits apparent in the
knockout mice are not related to visual and/or
motivational deficits. Further evidence that it is
long-term memory, but not short-term memory
that is affected in MIF/ mice, was obtained in the
Y-maze, in which animals did not differ in short- or
working-memory measures (data not shown).
Then, WT and MIF/ mice were tested in the
hippocampus-independent, but amygdala-dependent
acoustic fear-conditioning task (Figure 7c). When
Figure 4 Hippocampal cell proliferation and neurogenesis in MIF/ mice. Reduced expression of (a) PCNA (proliferation
marker), (b) DCX (neurogenesis marker), and (c) BrdU (cell survival and integration marker) IR cells in the SGZ of the dentate
gyrus of MIF/ mice compared with WT controls. (d) 14-day treatment with fluoxetine (10mgkg–1) increases the number of
PCNA IR cells in the dentate gyrus of WT, but MIF/ mice. (e) Chronic fluoxetine treatment (10mgkg–1 for 14 days) induces
increase in the number of MIF-IR cells in the SGZ of the dentate gyrus. (f) Hippocampal Ki67 positive cell number is reduced
after Iso-1 treatment (7mgkg–1 for 14 days). All data represents mean±s.e.m. *P<0.05, **P<0.01, and ***P<0.001
compared with corresponding control or as indicated.
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Figure 5 Corticosterone hormone and receptor levels in basal and stressed mice. (a) Basal (morning and evening; left panel,
n=4) and post-stress (15min or 30min; right panel, n=8) corticosterone levels did not differ in MIF/ compared with WT
mice. (b) Basal (left panel, n=10) and post-stress (right panel, n=8) levels of hippocampal corticosteroid (that is
mineralocorticoid and glucocorticoid) receptors were similar in both genotypes. All data represents mean±s.e.m.
Figure 6 Increased anxiety- and depressive-like symptoms in MIF/ mice. (a) Behavioral measurements in the EPM are
represented as frequency of entries in the different arms, (b) percent time spent in the different EPM areas and (c) distance
(cm) moved in the different arms. All data are group means (±s.e.m., N=28–30 per group). (d) Percentage time floating in
MIF/mice (n=5) is significantly longer than WT controls (n=6) in the FST, data are group means over the last 4min of the
test. *P<0.05, **P<0.01 vs WT.
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mice were placed in the conditioning apparatus,
both genotypes showed minimal freezing (WT:
2.64±1.06%; MIF/: 2.11±0.75%). On presentation
of the shock-tone combination during the training
session, MIF/ mice froze more during the post-
shock time than WT mice (P<0.01). During the test
given 24h later, MIF/ also showed significantly
higher freezing than WT mice (P<0.05). Our results
in the hot plate indicated that a differential nocicep-
tive sensitivity is unlikely to explain the observed
differences in the acoustic fear-conditioning test:
latencies to retract the paws in the hot-plate test were
equivalent for both genotypes (WT: 23.07±0.87 s;
MIF/: 20.80±1.42 s; n.s.). Altogether, these data
indicates that genetic deletion of MIF has profound
effects on anxiety- and depression-like behavior as
well as on learning and memory function.
Discussion
In this study, we have identified the expression of
MIF in astrocytes and, most notably, in neurogenic
cells in the SGZ of the rodent dentate gyrus and
characterized its presence in stem cells and in both
cells undergoing proliferation and in recently prolif-
erated cells undergoing maturation, but not in mature
neurons, microglia, or oligodendrocytes. We found
that, in the SGZ, MIF expression is modulated in
parallel to cell proliferation by treatments that are
well established for their modulatory actions on adult
hippocampal neurogenesis: stress, glucocorticoid,
and fluoxetine treatments. To assess for the causal
function of MIF in SGZ cell proliferation, we used
genetic and pharmacological approaches. Both, genet-
ic deletion of MIF and chronic treatment with the MIF
antagonist Iso-1 resulted in reduced cell proliferation
and MIF deletion also abolished the enhanced
proliferation induced by chronic fluoxetine treat-
ment. The behavioral phenotype of mice with genetic
deletion of MIF was indicative of increased anxiety-
and depression-like behaviors, as well as of impaired
hippocampus-dependent memory.
Our findings are in agreement with an earlier study
by Ogata et al.13 with regards to the identity of post-
mitotic cells expressing MIF (that is astrocytes, but
not mature neurons, microglia, or oligodendrocytes)
Figure 7 Impaired hippocampal-dependent spatial learning and memory, but intact amygdala-dependent fear conditioning
in MIF/ mice. (a) Male mice WT and MIF/ mice (n=10 per genotype) were trained in water maze for 3 acquisition days,
followed by a probe test and a visible platform test. MIF/ mice were profoundly impaired in acquisition of spatial reference
compared with WT mice. (b) Memory was tested by performance in the probe test conducted 24h after Trial 12. WT mice
showed a target compared with opposite quadrant preference that was absent in MIF/ mice. *P<0.05, ***P<0.0001. (c) In
the acoustic fear-conditioning test, MIF/ mice (n=7) showed significantly more freezing both during the training period
and recall (test) period compared with WT controls (n=8). *P<0.05, **P<0.01. All data are mean±s.e.m.
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and the first to identify MIF expression in hippo-
campal neurogenic cells. Although, in their paper,
Ogata et al.13 found mRNA expression in neurons and
astrocytes, in agreement with our data, protein
expression—as assessed by immunohistochemistry—
was restricted to astrocytes.
Our work reveals a new critical function for MIF in
adult hippocampal cell proliferation. This fits with
former studies that had reported MIF expression in
neurogenic areas in the CNS36 and identified prolif-
erative functions for MIF in non-brain tissues.37
Strikingly, our data from the gene knockout and
antagonist treatment approaches indicate a function
for MIF in hippocampal cell proliferation under basal
(that is antidepressant-independent) conditions for a
subset, but not the entire set of progenitor cells. This
contrasts with the effects of other molecular mechan-
isms, such as cyclin D2, found to be required for
virtually the entire basal hippocampal neurogenesis
observed in mice.38 Importantly, our study also
suggests that MIF is required for the stimulation of
hippocampal cell proliferation by antidepressants (at
least by the SSRI fluoxetine), highlighting MIF as a
potential important molecular target to develop novel
neurogenesis-related antidepressant treatments.
Conversely, the experiments involving chronic
stress or chronic corticosterone treatment showed
that MIF is an accompanying factor to the inhibitory
effects of these treatments on cell proliferation39–42
further supporting a function for MIF in basal (that is
non-antidepressant-induced) cell proliferation. How-
ever, these experiments do not allow discerning what
comes first as a consequence of stress and glucocorti-
coid treatments: whether MIF is first targeted and,
hence, hippocampal cell proliferation is inhibited or
the converse, MIF expression is reduced because of an
inhibitory effect in the dividing cells. Further experi-
ments with the MIF/ mice are required to directly
address the causal implication of MIF in stress-related
reduction in hippocampal cell proliferation. Given
the described modulatory actions of glucocorticoids
in hippocampal neurogenesis,43 we evaluated gluco-
corticoid responses and glucocorticoid regulatory
mechanisms in MIF/ mice. Importantly, no differ-
ences were found between MIF deficient and WT
mice in plasma corticosterone responses or in
hippocampal mineralocorticoid and glucocorticoid
receptors neither under basal conditions nor after
exposure to stress. These observations strongly sug-
gest that alterations in glucocorticoid-related levels
are not the cause for the reductions in neurogenesis
observed in the MIF/ mice.
Altogether, our immunohistochemical studies iden-
tify an interesting link between MIF expression in the
SGZ of the dentate gyrus and changes in neurogenesis
induced by antidepressant and stress-related treat-
ments. This raises the question of the potential
involvement of MIF in behaviors that have been
reported to be related (even when discrepancies in the
literature still exist) to the interaction between these
treatments and hippocampal neurogenesis.27,30,31,44,45
To address this issue, we tested MIF/ mice for their
anxiety- and depression-like behaviors, as well as for
their hippocampus-dependent and -independent
learning.
Our behavioral results collectively indicate that
MIF deficiency is associated with a phenotype
characterized by increased anxiety- (as evaluated in
the EPM) and depression-like (as evaluated in the
FST) behaviors, as well as by impaired hippocampus-
dependent (as evaluated in the water maze) memory
function. Studies based on strategies aimed at redu-
cing neurogenesis in mice, such as focal hippocampal
irradiation, initially proposed that a decrease in
neurogenesis per se does not induce behavioral
symptoms associated with depression,27,46–48 but
rather, that neurogenesis is required for some of the
behavioral effects of the antidepressant drugs;27,49 but
see also Refs 50,51 for evidence indicating that
antidepressant effects on depression-like behaviors
are not dependent on neurogenesis. More recent
studies with alternative approaches have supported
a role for neurogenesis in anxiety.52–54 One of the most
conclusive evidence was obtained with transgenic
mice in which hippocampal neurogenesis was speci-
fically impaired (through the over-expression of the
pro-apoptotic protein Bax in neuronal precursors).
These mice exhibited a striking increase in anxiety-
related behaviors (as evaluated among other tests in
the EPM), whereas depression-like behaviors (as
evaluated among other tests in the FST) were not
affected.30 Recently, an important modulatory func-
tion has been proposed for anxiety on hippocampal
cell proliferation involving both amygdala-dependent
and -independent mechanisms.55 Our present data
further supports a key function for hippocampal
neurogenesis (and hence of MIF as an important
molecular pathway regulating cell proliferation) in
anxiety-like behavior.
However, given the lack of clear evidence in the
existing literature linking a deficit in neurogenesis
with depression-like behavior under basal (that is not
antidepressant-stimulated) conditions, we should be
cautious about the conclusions that can be drawn
from the FST data. Among the possible explanations
that can be put forward are (i) that there is a link
between MIF expression and depression-like behavior
in the FST that is independent of hippocampal
neurogenesis; (ii) that the genetic deletion of MIF
might have modified other biological factors, which
are critical for the expression of this depression-like
behavior; (iii) that the depression-like behavior
observed in MIF/ mice is the emerging result of
having exposed these mice with their heightened
anxiety levels to a series of experimental conditions
before being tested in the FST. Although our data does
not allow us to assert or to exclude any of these
possibilities, a pilot study performed in behaviorally
naive mice, and showing no differences in the FST
between the two genotypes, gave support to the latter.
In addition, this hypothesis is in line with substantial
experimental and clinical evidence supporting a key
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function for high anxiety trait in the emergence of
depression.56
Our learning results also support a strong link
between MIF expression and hippocampus-depen-
dent learning. MIF/ mice were impaired in their
formation of a long-term memory for the platform
location in the water maze. It is noteworthy that
within each training session, these mice were able to
learn and that their deficit was circumscribed to the
maintenance of the memory into a long-term storage
(as indicated by their recall failure on the first trial of
training session 3 and in the probe trial). Specificity
of this deficit for a hippocampus-dependent memory
was supported by the lack of deficit found in the
MIF/ mice in a hippocampus-independent (amyg-
dala-dependent) learning task, the acoustic fear
conditioning. In fact, the MIF/ mice showed higher
fear responses than WT mice both during training and
testing, which might be a reflection of their more
anxious phenotype instead of a reflection of enhanced
fear memory (note that no differences between the
two genotypes are observed when the ratio between
freezing at testing and freezing at training is con-
sidered). In this connection, it is important to
mention that a recent study has shown an upregula-
tion of the MIF receptor, CD74, after high-frequency
long-term potentiation induction.57 Although, to our
knowledge, it is not as yet known whether CD74 is
expressed in neural precursors, recent work has
revealed its expression in microglia and neurons.58
Long-term potentiation can induce proliferation of
progenitor cells in the dentate gyrus.59,60 In light of the
proposed function here for MIF in adult neurogenesis,
these two events may be linked. However, again a
note of caution should be added to remind that other
factors (developmental, others) might also account for
the learning deficits observed in our MIF/ mice.
Although hotly debated, a function for neurogen-
esis in hippocampus-dependent learning and mem-
ory has been proposed. Several lines of evidence
support this hypothesis: (i) strong correlation be-
tween the rate of neurogenesis and spatial learning in
the water maze among mice inbred strains61 and in
old rats from an outbreed strain.62 (ii) manipulations
in which inhibiting hippocampal neurogenesis
resulted in hippocampus-dependent learning defi-
cits;32,45,63 and (iii) observations that learning itself
can enhance the survival rate of new hippocampal
neurons,64–66 and induce apoptosis of more immature
cells and proliferation of neural precursors.67 How-
ever, other studies found the opposite (that is
negative) correlation between the rate of hippocampal
cell proliferation and spatial learning68 or failed to
find deficits in hippocampus-dependent learning
after ablation of hippocampal neurogenesis.46,69,70
Recent evidence using both local X-irradiation and
genetic approaches has revealed a key function for
hippocampal neurogenesis in spatial pattern separa-
tion, a key cognitive function of the dentate gyrus.71
Our study adds to the positive evidence accumulated
in this debate establishing a link between hippocam-
pal neurogenesis and the formation of long-term
spatial memories and goes beyond by highlighting
MIF as a key factor in these mnemonic processes.
A recent study72 has identified MIF as a possible
susceptibility gene for autism spectrum disorder. The
authors found genetic associations between known
functional polymorphisms in the promoter for MIF
and autism spectrum disorder-related behaviors.
Moreover, probands with autism spectrum disorder
were reported to exhibit higher plasma MIF levels
than their unaffected siblings, and these levels
correlated with the severity of multiple autism
spectrum disorder symptoms. These findings raise
the intriguing possibility that some of our current
findings might have implications for the understand-
ing of the neurobiological mechanisms implicated in
autism.
In conclusion, we provide evidence supporting a
pivotal function for MIF in both basal and antide-
pressant-stimulated adult hippocampal cell prolifera-
tion (and hence, eventually neurogenesis). We also
showed that, in addition to affecting cell proliferation
in the dentate gyrus, loss of MIF results in a
behavioral phenotype (increased anxiety- and depres-
sion-like behaviors, and impaired hippocampus-de-
pendent spatial learning) that to a large extent
corresponds with alterations that would be predicted
from reduced hippocampal neurogenesis. Altogether,
these findings underscore MIF as a potentially
relevant molecular target for the development of
treatments linked to deficits in neurogenesis, as well
as to problems related to anxiety, depression, and
cognition.
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